Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CMTM6 is positively correlated with PD-L1 expression and immune cells infiltration in lung squamous carcinoma.

International immunopharmacology - 1 Nov 2020

Shang Xiaoling, Li Jia, Wang Hui, Li Zhenxiang, Lin Jiamao, Chen Dawei, Wang Haiyong

Abstract excerpt

BACKGROUND: The aim of this study was to clarify the association between CMTM6 and PD-L1 expression as well as microenvironment in lung squamous carcinoma (LUSC). MATERIAL AND METHODS: Using Spearman's correlation and Tumor Immune Estimation Resource (TIMER), we analyzed the relationship between CMTM6 and PD-L1 mRNA in LUSC. Immunohistochemistry (IHC) assay was applied to validate the correlation between CMTM6...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Databases, Genetic

Share to Gene Expression Regulation, Neoplastic

Share to Lung Neoplasms

Share to Lymphocytes, Tumor-Infiltrating

Share to Myelin Proteins

Share to Tumor Microenvironment

Source

Identifiers

PMID: 32866782
DOI: 10.1016/j.intimp.2020.106864

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CMTM6 is positively correlated with PD-L1 expression and immune cells infiltration in lung squamous carcinoma.PMID 32866782Read ↗

M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancerSemantic proximity Read ↗

Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell CarcinomaSemantic proximity Read ↗

CMTM6, the newly identified PD-L1 regulator, correlates with PD-L1 expression in lung cancersSemantic proximity Read ↗

Prognostic Implications of Pan-cancer CMTM6 Expression and Its Relationship With the Immune MicroenvironmentSemantic proximity Read ↗

Analyses of multi-omics differences between patients with high and low PD1/PDL1 expression in lung squamous cell carcinoma.Semantic proximity Read ↗

Molecular and immune characteristics for lung adenocarcinoma patients with CMTM6 overexpressionSemantic proximity Read ↗

TGM2 Has Potential to Be A Prognostic Factor for Lung Squamous Cell Carcinoma and an Indicator of Immune InfiltratesSemantic proximity Read ↗

IGSF6 is a biomarker associated with anti-tumor immune response in lung adenocarcinomaSemantic proximity Read ↗

CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironmentSemantic proximity Read ↗

IGSF6 is a prognostic biomarker associated with the anti-tumor activity of macrophages in lung adenocarcinomaSemantic proximity Read ↗

Immunoglobulin superfamily 6-mediated immune signature determines prognosis and immune landscape in lung adenocarcinomaSemantic proximity Read ↗

Development and validation of an individualized immune prognostic model in stage I-III lung squamous cell carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.